18.1% of MSGR Holdings Seeing Recent Insider Buys
January 13, 2022 at 09:40 AM EST
A look at the weighted underlying holdings of the Direxion mRNA ETF (MSGR) shows an impressive 18.1% of holdings on a weighted basis have experienced insider buying within the past six months. Start slideshow:10 ETFs With Stocks That Insiders Are Buying » Sarepta Therapeutics Inc (SRPT), which makes up 4.70% of the Direxion mRNA ETF (MSGR), has seen 2 directors and officers purchase shares in the past six months, according to the recent Form 4 data.